Bibliographic Details
| Title: |
A Meta-Analysis and Meta-Regression of Embolisation Outcomes of Pulmonary Arteriovenous Malformations: Y. Shahin et al.: A Meta-Analysis and Meta-Regression of Embolisation... |
| Authors: |
Shahin, Yousef, Vijayakumar, Cyrilkumaar, Gill, Amarit, Lejawka, Andrzej, Bennett, Steve, Willis, Rebecca, Abbas, Mustafa, Kusumawidjaja, Daniel |
| Source: |
CardioVascular & Interventional Radiology; Feb2025, Vol. 48 Issue 2, p167-179, 13p |
| Subject Terms: |
ARTERIOVENOUS malformation, TELANGIECTASIA, MEDLINE, HETEROGENEITY, MORPHOLOGY, THERAPEUTIC embolization |
| Abstract: |
Purpose: Embolisation is a widely utilised therapeutic intervention for pulmonary arteriovenous malformation (PAVM). We conducted a meta-analysis to evaluate outcomes of PAVM embolisation and factors associated with embolisation outcomes. Methods: MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) were searched from 2000 to July 2022 on studies that assessed embolisation outcomes of PAVM. Immediate technical success rate defined as the complete occlusion of the PAVM at the time of embolisation and treatment success rate defined as ≥ 70% venous sac reduction on follow-up imaging were pooled from included studies with use of random effects proportion meta-analysis. Heterogeneity across studies was assessed with the I2 statistic. Results: Forty-four studies including 1865 patients (604 (32%) males, mean age (range) 45 (24–59) years, 1125 (60%) had hereditary haemorrhagic telangiectasia (HHT)) were included in the meta-analysis. Studies included a total of 4314 PAVMs of which 4047 (94%) were treated. Studies reported morphology of 3074 PAVMs (2519 (58%) simple and 555 (13%) complex). The pooled overall immediate technical success rate for PAVM embolisation was 99%, 95% CI (98–100%) and the treatment success rate was 86%, 95% CI (84–89%). Younger age (p = 0.041), simple PAVM (0.020), and embolisation using plugs (p = 0.001) were associated with higher treatment success. Feeding artery and sac embolisation (p = 0.021) and using coils (p = 0.001) were associated with lower treatment success. There was no significant difference in recanalisation rate between different embolisation agents (OR 0.64, 95% CI −0.09– 1.38). Conclusion: This meta-analysis shows that PAVM embolisation is safe and effective. Higher treatment success rates for PAVM embolisation can be achieved using plugs as the primary embolisation agent. Embolisation agent used had no effect on recanalisation rates. [ABSTRACT FROM AUTHOR] |
|
Copyright of CardioVascular & Interventional Radiology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
